293 related articles for article (PubMed ID: 37958472)
1. Potential Associations between Vascular Biology and Hodgkin's Lymphoma: An Overview.
Rodrigues WF; Miguel CB; Abreu MCM; Neto JM; Oliveira CJF
Cancers (Basel); 2023 Nov; 15(21):. PubMed ID: 37958472
[TBL] [Abstract][Full Text] [Related]
2. Cytokine production (IL-1 alpha, IL-1 beta, and TNF alpha) and endothelial cell activation (ELAM-1 and HLA-DR) in reactive lymphadenitis, Hodgkin's disease, and in non-Hodgkin's lymphomas. An immunocytochemical study.
Ruco LP; Pomponi D; Pigott R; Stoppacciaro A; Monardo F; Uccini S; Boraschi D; Tagliabue A; Santoni A; Dejana E
Am J Pathol; 1990 Nov; 137(5):1163-71. PubMed ID: 1700619
[TBL] [Abstract][Full Text] [Related]
3. Expression and cell distribution of the intercellular adhesion molecule, vascular cell adhesion molecule, endothelial leukocyte adhesion molecule, and endothelial cell adhesion molecule (CD31) in reactive human lymph nodes and in Hodgkin's disease.
Ruco LP; Pomponi D; Pigott R; Gearing AJ; Baiocchini A; Baroni CD
Am J Pathol; 1992 Jun; 140(6):1337-44. PubMed ID: 1605306
[TBL] [Abstract][Full Text] [Related]
4. Real-time polymerase chain reaction determination of cytokine mRNA expression profiles in Hodgkin's lymphoma.
Malec M; Söderqvist M; Sirsjö A; MacNamara B; Lewin N; Sjöberg J; Björkholm M; Porwit-MacDonald A
Haematologica; 2004 Jun; 89(6):679-85. PubMed ID: 15194535
[TBL] [Abstract][Full Text] [Related]
5. Hodgkin's lymphoma: molecular targets and novel treatment strategies.
Yazbeck V; Georgakis GV; Wedgwood A; Younes A
Future Oncol; 2006 Aug; 2(4):533-51. PubMed ID: 16922620
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of heat shock protein 90 function by 17-allylamino-17-demethoxy-geldanamycin in Hodgkin's lymphoma cells down-regulates Akt kinase, dephosphorylates extracellular signal-regulated kinase, and induces cell cycle arrest and cell death.
Georgakis GV; Li Y; Rassidakis GZ; Martinez-Valdez H; Medeiros LJ; Younes A
Clin Cancer Res; 2006 Jan; 12(2):584-90. PubMed ID: 16428504
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneity of dermal microvascular endothelial cell antigen expression and cytokine responsiveness in situ and in cell culture.
Petzelbauer P; Bender JR; Wilson J; Pober JS
J Immunol; 1993 Nov; 151(9):5062-72. PubMed ID: 7691964
[TBL] [Abstract][Full Text] [Related]
8. Analysis of T cell stimulation by superantigen plus major histocompatibility complex class II molecules or by CD3 monoclonal antibody: costimulation by purified adhesion ligands VCAM-1, ICAM-1, but not ELAM-1.
van Seventer GA; Newman W; Shimizu Y; Nutman TB; Tanaka Y; Horgan KJ; Gopal TV; Ennis E; O'Sullivan D; Grey H
J Exp Med; 1991 Oct; 174(4):901-13. PubMed ID: 1717633
[TBL] [Abstract][Full Text] [Related]
9. Augmented efficacy of brentuximab vedotin combined with ruxolitinib and/or Navitoclax in a murine model of human Hodgkin's lymphoma.
Ju W; Zhang M; Wilson KM; Petrus MN; Bamford RN; Zhang X; Guha R; Ferrer M; Thomas CJ; Waldmann TA
Proc Natl Acad Sci U S A; 2016 Feb; 113(6):1624-9. PubMed ID: 26811457
[TBL] [Abstract][Full Text] [Related]
10. Deficient major histocompatibility complex class II antigen presentation in a subset of Hodgkin's disease tumor cells.
Bosshart H; Jarrett RF
Blood; 1998 Oct; 92(7):2252-9. PubMed ID: 9746762
[TBL] [Abstract][Full Text] [Related]
11. Non-Hodgkin's lymphoma after prolonged remission of Hodgkin's disease in an HIV-infected patient.
Montalban C; Bellas C; Rodriguez-Garcia JL; Aguado M; Fernandez-Muñoz R
Ann Oncol; 1991 Sep; 2(8):585-7. PubMed ID: 1665342
[TBL] [Abstract][Full Text] [Related]
12. Advances in the treatment of Hodgkin's lymphoma (Review).
Che Y; Ding X; Xu L; Zhao J; Zhang X; Li N; Sun X
Int J Oncol; 2023 May; 62(5):. PubMed ID: 37026506
[TBL] [Abstract][Full Text] [Related]
13. The expression of fibroblast growth factors and their receptors in Hodgkin's lymphoma.
Khnykin D; Troen G; Berner JM; Delabie J
J Pathol; 2006 Feb; 208(3):431-8. PubMed ID: 16353171
[TBL] [Abstract][Full Text] [Related]
14. Effect of human cytokines (IFN-gamma, TNF-alpha, IL-1 beta, IL-4) on porcine endothelial cells: induction of MHC and adhesion molecules and functional significance of these changes.
Batten P; Yacoub MH; Rose ML
Immunology; 1996 Jan; 87(1):127-33. PubMed ID: 8666424
[TBL] [Abstract][Full Text] [Related]
15. Hodgkin's Disease and Anaplastic Large Cell Lymphoma Revisited. 1. unique cytokine and cytokine receptor profile distinguished from that of non-hodgkin's lymphomas.
Hsu SM; Waldron J; Xie SS; Hsu PL
J Biomed Sci; 1995 Oct; 2(4):302-313. PubMed ID: 11725067
[TBL] [Abstract][Full Text] [Related]
16. Preliminary report: growth of Hodgkin's lymphoma derived cells in immune compromised mice.
Kapp U; Wolf J; von Kalle C; Tawadros S; Röttgen A; Engert A; Fonatsch C; Stein H; Diehl V
Ann Oncol; 1992 Sep; 3 Suppl 4():21-3. PubMed ID: 1450076
[TBL] [Abstract][Full Text] [Related]
17. KIR genotype distribution among Lebanese patients with Hodgkin's lymphoma.
Hoteit R; Abboud M; Bazarbachi A; Salem Z; Shammaa D; Zaatari G; Mahfouz R
Meta Gene; 2015 Jun; 4():57-63. PubMed ID: 25853061
[TBL] [Abstract][Full Text] [Related]
18. Fine-needle aspiration cytology of metastatic nasopharyngeal carcinoma in cervical lymph nodes: comparison with metastatic squamous-cell carcinoma, and Hodgkin's and non-Hodgkin's lymphoma.
Kollur SM; El Hag IA
Diagn Cytopathol; 2003 Jan; 28(1):18-22. PubMed ID: 12508177
[TBL] [Abstract][Full Text] [Related]
19. The B7/BB1 antigen is expressed by Reed-Sternberg cells of Hodgkin's disease and contributes to the stimulating capacity of Hodgkin's disease-derived cell lines.
Delabie J; Ceuppens JL; Vandenberghe P; de Boer M; Coorevits L; De Wolf-Peeters C
Blood; 1993 Nov; 82(9):2845-52. PubMed ID: 7693051
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
